Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$74.85

0.81 (1.09%)

09:01
09/30/19
09/30
09:01
09/30/19
09:01

UBS healthcare/pharma analysts to hold an analyst/industry conference call

Analysts discuss the underlying thesis for the AbbVie upgrade on an Analyst/Industry conference call to be held on September 30 at 10 am.

ABBV AbbVie
$74.85

0.81 (1.09%)

09/25/19
PIPR
09/25/19
NO CHANGE
Target $81
PIPR
Overweight
AbbVie survey supports above-consensus estimates, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on AbbVie (ABBV) shares with an $81 price target following a new rheumatologist survey by his firm's partners Spherix Global Insights. The survey indicates "robust" expectations for the company's oral JAK1 inhibitor Rinvoq, Raymond tells investors in a research note. Rheumatologists project that in six months, Rinvoq will leapfrog Eli Lilly's (LLY) Olumiant to become the second-most prescribed JAK with 5% share, says the analyst, citing the survey. He believes this supports his above-consensus Rinvoq revenue estimates.
09/26/19
SBSH
09/26/19
UPGRADE
SBSH
Buy
AbbVie upgraded to Buy from Neutral at Citi
Citi analyst Andrew Baum upgraded AbbVie to Buy from Neutral.
09/26/19
SBSH
09/26/19
UPGRADE
Target $90
SBSH
Buy
Citi upgrades AbbVie to Buy, sees 'significant' value from Allergan deal
Citi analyst Andrew Baum upgraded AbbVie to Buy from Neutral and raised his price target for the shares to $90 from $87. The analyst believes AbbVie will "extract significant shareholder value" from Allergan's (AGN) franchises given its "strong commercial focus and patient/physician centricity." Further, within AbbVie's organic portfolio, Baum continues to think the market underappreciates the revenue potential of both Skyrizi and Rinvoq.
09/26/19
09/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Outperform from Market Perform at Wells Fargo analyst Timothy Willi saying the company's fundamentals remain strong while investor sentiment is "overly negative and close to inflecting." 2. Whirlpool (WHR) upgraded to Overweight from Neutral at JPMorgan with analyst Michael Rehaut saying he expects U.S. industry shipments to be more stable year-over-year through the end of 2019 and show "modest" growth in 2020. 3. Boston Beer (SAM) upgraded to Outperform from Market Perform at BMO Capital with analyst Amit Sharma saying Truly is "primed to capture" strong consumer demand and higher distribution/shelf space for hard seltzer. 4. AbbVie (ABBV) upgraded to Buy from Neutral at Citi with analyst Andrew Baum saying he believes AbbVie will "extract significant shareholder value" from Allergan's (AGN) franchises given its "strong commercial focus and patient/physician centricity." 5. Hologic (HOLX) upgraded to Buy from Neutral at BofA/Merrill with analyst Ivy Ma saying she sees the company being on "steadier footing with organic growth upside in FY20" thanks to its tuck-in acquisitions. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CIEN

Ciena

$38.04

0.26 (0.69%)

11:35
11/12/19
11/12
11:35
11/12/19
11:35
Options
Ciena put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCUL

Ocular Therapeutix

$2.72

-0.205 (-7.01%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Recommendations
Ocular Therapeutix analyst commentary  »

Ocular Therapeutix price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

NVTA

Invitae

$16.90

-0.93 (-5.22%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Options
Invitae call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHDN

Churchill Downs

$126.44

0.1 (0.08%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Hot Stocks
Churchill Downs announces launch of retail sportsbook in Indiana »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$47.20

0.32 (0.68%)

, FGEN

FibroGen

$35.67

0.3 (0.85%)

11:25
11/12/19
11/12
11:25
11/12/19
11:25
Conference/Events
Cowen biotechnology analysts to hold an analyst/industry conference call »

Biotech Analysts Werber…

AZN

AstraZeneca

$47.20

0.32 (0.68%)

FGEN

FibroGen

$35.67

0.3 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 18

    Nov

  • 07

    Dec

ABBV

AbbVie

$87.72

2.08 (2.43%)

11:20
11/12/19
11/12
11:20
11/12/19
11:20
Hot Stocks
AbbVie reports 'positive' data from Phase 2/3 SELECT-AXIS 1 trial »

AbbVie announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AOBC

American Outdoor Brands

$7.87

-0.29 (-3.55%)

, VSTO

Vista Outdoor

$9.80

-0.1 (-1.01%)

11:17
11/12/19
11/12
11:17
11/12/19
11:17
Hot Stocks
Gunmakers slide as Supreme Court lets Sandy Hook families sue »

The U.S. Supreme Court…

AOBC

American Outdoor Brands

$7.87

-0.29 (-3.55%)

VSTO

Vista Outdoor

$9.80

-0.1 (-1.01%)

RGR

Sturm, Ruger

$44.50

-0.64 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/12/19
11/12
11:17
11/12/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/12/19
11/12
11:16
11/12/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$211.70

3.56 (1.71%)

, AMD

AMD

$36.96

0.66 (1.82%)

11:15
11/12/19
11/12
11:15
11/12/19
11:15
Recommendations
Nvidia, AMD analyst commentary  »

Nvidia price target…

NVDA

Nvidia

$211.70

3.56 (1.71%)

AMD

AMD

$36.96

0.66 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 09

    Dec

AGN

Allergan

$183.63

3.59 (1.99%)

11:15
11/12/19
11/12
11:15
11/12/19
11:15
Options
Allergan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/12/19
11/12
11:15
11/12/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
11/12/19
11/12
11:15
11/12/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:10
11/12/19
11/12
11:10
11/12/19
11:10
General news
Treasury announced $95 B in 4- and 8-week bill auctions for Thursday »

Treasury announced $95 B…

ESPR

Esperion

$41.00

2.25 (5.81%)

11:09
11/12/19
11/12
11:09
11/12/19
11:09
Hot Stocks
Esperion announces publication of results of Phase 3 study of bempedoic acid »

Esperion announce that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

BA

Boeing

$362.38

-4.59 (-1.25%)

11:05
11/12/19
11/12
11:05
11/12/19
11:05
Hot Stocks
Boeing reports -95 net commercial plane orders through Oct. 31, 2019 »

In an update posted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

IGT

International Game

$13.18

-0.31 (-2.30%)

11:05
11/12/19
11/12
11:05
11/12/19
11:05
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TTD

Trade Desk

$223.58

6.47 (2.98%)

, AMZN

Amazon.com

$1,785.43

13.73 (0.77%)

11:04
11/12/19
11/12
11:04
11/12/19
11:04
Hot Stocks
Trade Desk announces retirement of CFO Paul Ross »

The Trade Desk (TTD)…

TTD

Trade Desk

$223.58

6.47 (2.98%)

AMZN

Amazon.com

$1,785.43

13.73 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

LKFN

Lakeland Financial

$47.28

0.13 (0.28%)

11:02
11/12/19
11/12
11:02
11/12/19
11:02
Hot Stocks
Lakeland Financial appoints Rick Donovan as General Counsel »

Lake City Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
11/12/19
11/12
11:01
11/12/19
11:01
Conference/Events
Wedbush tech strategist to hold an analyst/industry conference call »

Technology Strategist…

RUN

Sunrun

$14.61

0.2 (1.39%)

10:55
11/12/19
11/12
10:55
11/12/19
10:55
Options
Sunrun put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 04

    Dec

10:55
11/12/19
11/12
10:55
11/12/19
10:55
Conference/Events
Economic Club of New York to host President Trump »

President Trump to…

DOX

Amdocs

$67.14

0.12 (0.18%)

10:54
11/12/19
11/12
10:54
11/12/19
10:54
Conference/Events
Amdocs management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

VRTX

Vertex

$203.56

1.66 (0.82%)

10:53
11/12/19
11/12
10:53
11/12/19
10:53
Hot Stocks
Vertex confirms Northern Ireland offer accepted for cystic fibrosis medicines »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ABBV

AbbVie

$87.46

1.82 (2.13%)

, AGN

Allergan

$182.96

2.92 (1.62%)

10:52
11/12/19
11/12
10:52
11/12/19
10:52
Periodicals
AbbVie preps $27B bond sale to finance Allergan deal, FT reports »

AbbVie (ABBV) is readying…

ABBV

AbbVie

$87.46

1.82 (2.13%)

AGN

Allergan

$182.96

2.92 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.